Foresee Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	479.52	1,367	1,010	689.51	871.44
Short-Term Investments	220.7	-	150	-	100
Trading Asset Securities	-	-	-	-	297.47
Cash & Short-Term Investments	700.22	1,367	1,160	689.51	1,269
Cash Growth	-48.79%	17.90%	68.19%	-45.66%	-21.76%
Accounts Receivable	43.48	32.33	65.91	16.27	-
Other Receivables	9.23	26.55	22.18	10.13	5.73
Receivables	52.72	58.88	88.09	26.4	5.73
Inventory	144.71	183.87	126.8	176.41	24.88
Prepaid Expenses	88.07	132.48	23.56	22.75	3.9
Other Current Assets	-	75	192.5	-	-
Total Current Assets	985.71	1,818	1,591	915.06	1,303
Property, Plant & Equipment	207.16	217.62	135.01	142.39	91.19
Other Intangible Assets	111.14	117.79	126.81	140.96	155.14
Long-Term Deferred Tax Assets	1.25	1.31	1.23	1.22	1.1
Other Long-Term Assets	5.13	4.9	7.76	104.39	90.58
Total Assets	1,310	2,159	1,861	1,304	1,641
Accounts Payable	16.57	64.42	12.13	22.85	-
Accrued Expenses	7.31	85.57	120.71	78.47	61.68
Short-Term Debt	197	150	200	-	-
Current Portion of Long-Term Debt	-	5	-	-	-
Current Portion of Leases	14.23	12.41	15.14	15.52	10.2
Current Income Taxes Payable	11.47	8.82	10.42	4.95	-
Current Unearned Revenue	-	50.03	105.48	1.01	0.78
Other Current Liabilities	39.71	16.97	6.96	6.38	1.79
Total Current Liabilities	286.3	393.21	470.83	129.17	74.45
Long-Term Debt	-	92.92	-	-	-
Long-Term Leases	20.51	-	13.12	25.8	6.45
Long-Term Unearned Revenue	72.62	72.62	131.67	237.15	239.17
Long-Term Deferred Tax Liabilities	1.35	1.41	1.32	1.32	1.19
Total Liabilities	380.78	560.15	616.93	393.43	321.26
Common Stock	1,575	1,548	1,358	1,182	1,179
Additional Paid-In Capital	6,087	5,906	4,617	3,424	3,372
Retained Earnings	-6,694	-5,811	-4,730	-3,693	-3,221
Comprehensive Income & Other	-38.86	-44.56	-1.49	-1.54	-10.21
Shareholders' Equity	929.61	1,599	1,245	910.58	1,320
Total Liabilities & Equity	1,310	2,159	1,861	1,304	1,641
Total Debt	231.74	260.33	228.26	41.32	16.65
Net Cash (Debt)	468.48	1,107	931.42	648.19	1,252
Net Cash Growth	-57.68%	18.85%	43.70%	-48.24%	-16.05%
Net Cash Per Share	3.02	8.06	7.32	5.49	10.67
Filing Date Shares Outstanding	157.28	154.79	135.82	118.17	117.94
Total Common Shares Outstanding	157.28	154.79	135.82	118.17	117.94
Working Capital	699.41	1,424	1,120	785.89	1,229
Book Value Per Share	5.91	10.33	9.16	7.71	11.19
Tangible Book Value	818.47	1,481	1,118	769.62	1,165
Tangible Book Value Per Share	5.20	9.57	8.23	6.51	9.88
Land	-	123.07	-	-	-
Buildings	-	9.96	-	-	-
Machinery	-	226.59	209.45	171.58	136.94
Construction In Progress	-	-	4.9	20.39	4.4
Leasehold Improvements	-	30.44	30.44	7.71	7.71

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.